NCT04131257

Brief Summary

The study aims to improve diabetes prevention, access to care and advocacy through a novel cost-effective nurse-led continuum of care approach that incorporates diabetes prevention, awareness, screening and management for low-income settings, and furthermore utilizes the endeavor to advocate for establishing standard diabetes program in Nepal.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,236

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Dec 2019

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 18, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

October 18, 2019

Status Verified

October 1, 2019

Enrollment Period

1 year

First QC Date

October 15, 2019

Last Update Submit

October 16, 2019

Conditions

Keywords

Continuum of careDiabetesPre-diabetes

Outcome Measures

Primary Outcomes (2)

  • Change in Glycated Hemoglobin (HbA1c) level

    The HbA1c will be measured using Boronate affinity chromatography (Axis-Shield, Norway)

    Baseline, 6 months, 12 months

  • Change in the incidence of diabetes among individuals with pre-diabetes

    Electronic Health Record will be used to measure the incidence of diabetes

    6 months, 12 months

Secondary Outcomes (7)

  • Change in Blood Pressure

    Baseline, 6 months, 12 months

  • Change in lipid profile levels (HDL, LDL, Triglycerides, Total cholesterol)

    Baseline, 6 months, 12 months

  • Change in Body Mass Index

    Baseline, 6 months, 12 months

  • Change in the "Reach" of people participating in the program

    6 months, 12 months

  • Change in the "Adoption at the patient level" measured by the Summary of Diabetes Self-Care Activities Scale

    Baseline, 6 months, 12 months

  • +2 more secondary outcomes

Study Arms (2)

Continuum of care

EXPERIMENTAL

Trained diabetes nurses will provide continuum of care to the participants that includes: conducting community awareness campaigns, screening programs, linkage to clinical care, community follow-up counseling and support for individuals with diabetes, and prevention programs for individuals with pre-diabetes.

Behavioral: Nurse-led Continuum of Care

Usual care

ACTIVE COMPARATOR

The control group will receive usual diabetic care without the nurse coordination and supervision as in the intervention group.

Behavioral: Nurse-led Continuum of Care

Interventions

This will be a nurse-led community level prevention program for individuals with diabetes and pre-diabetes, where participants in intervention group will receive nurse-led continuum of care while control group will receive usual diabetic care.

Continuum of careUsual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • with confirmed pre-existing type II diabetes and prediabetes at the time of our screening (i.e., pre-existing diabetes or prediabetes)
  • with confirmed diagnosis of type II diabetes or prediabetes after our community screening process (i.e., newly diagnosed diabetes and prediabetes)
  • is not planning to relocate outside of the current place of living in next 2 years
  • is older than 18 years of age

You may not qualify if:

  • are not psychologically capable of communication
  • are diagnosed as type 1 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Xu DR, Dev R, Shrestha A, Zhang L, Shrestha A, Shakya P, Hughes JP, Shakya PR, Li J, Liao J, Karmacharya BM. NUrse-led COntinuum of care for people with Diabetes and prediabetes (NUCOD) in Nepal: study protocol for a cluster randomized controlled trial. Trials. 2020 May 29;21(1):442. doi: 10.1186/s13063-020-04372-5.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes MellitusGlucose Intolerance

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemia

Study Officials

  • Biraj M Karmacharya, PhD

    Kathmandu University School of Medical Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 15, 2019

First Posted

October 18, 2019

Study Start

December 1, 2019

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

October 18, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcome will be made available.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will be available within 6 months of study completion.
Access Criteria
Data access requests will be reviewed by an external Independent Review Panel. Requestors will be required to sign a Data Access Agreement.